Acusphere registers $100 million shelf

By Ted A. Knutson

Washington, Dec. 23 - Acusphere Inc. filed for a $100 million shelf in an S-3 registration with the Securities and Exchange Commission.

Included within the shelf are senior debt securities, common stock, preferred stock, subordinated debt securities and warrants. The language in the shelf also allows for convertibles.

Acusphere, a Boston drug developer, said shelf drawdowns would be spent on general corporate purposes, which may include clinical trials, research and development, regulatory activities, the build-out of a pharmaceutical manufacturing facility in Tewksbury, Mass., acquisitions, repayment or refinancing of existing debt, investments, capital expenditures, the repurchase of capital stock and other priorities.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.